---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-056224"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:42:38.269557+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Unicycive Therapeutics doubles authorized common stock to 400M shares

## Summary
- Stockholders approved increase from 200M to 400M shares on June 20, 2024.
- Certificate of Amendment filed with Delaware on June 21, 2024, effective immediately.
- No specific use of the additional shares or dilution impact disclosed.

## SEC filing metadata
- accession: 0001213900-24-056224
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024056224/0001213900-24-056224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024056224/ea0208510-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-056224
- JSON: https://secwatch.observer/filing/0001213900-24-056224.json
- Plain text: https://secwatch.observer/filing/0001213900-24-056224.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.